Analyst Price Targets — MED
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 19, 2026 12:13 pm | — | Stephens | $12.00 | $10.71 | TheFly | Medifast price target lowered to $12 from $15 at Stephens |
| November 5, 2024 12:41 pm | Linda Bolton Weiser | D.A. Davidson | $17.00 | $20.40 | StreetInsider | DA Davidson Upgrades Medifast (MED) to Neutral |
| June 5, 2024 6:07 am | Linda Bolton Weiser | D.A. Davidson | $17.50 | $23.97 | StreetInsider | DA Davidson Downgrades Medifast (MED) to Underperform |
| April 30, 2024 5:00 am | Linda Bolton Weiser | D.A. Davidson | $25.00 | $35.51 | StreetInsider | Medifast (MED) PT Lowered to $25 at DA Davidson |
| June 5, 2023 9:09 am | Stephanie Wissink | Jefferies | $150.00 | $81.22 | Benzinga | Wall Street's Most Accurate Analysts Say Hold These 3 Defensive Stocks With Over 6% Dividend Yields |
| April 6, 2023 8:52 am | Linda Bolton Weiser | D.A. Davidson | $94.00 | $96.39 | Benzinga | Check Out 3 High-Yielding Dividend Stocks In Defensive Sector From Wall Street's Most Accurate Analysts |
Latest News for MED
NEW YORK, April 14, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Medifast, Inc. (NYSE: MED) on behalf of the company's shareholders. The investigation seeks to determine whether Medifast's directors breached their fiduciary duties in connection with recent corporate actions.
MED's science-led metabolic health push and new product pipeline could spark a turnaround as it targets GLP-1 transition users and profitability growth.
Medifast Inc (NYSE: MED - Get Free Report) CEO Daniel Chard acquired 17,678 shares of the stock in a transaction on Friday, March 20th. The stock was bought at an average price of $10.11 per share, with a total value of $178,724.58. Following the transaction, the chief executive officer directly owned 17,678 shares in the company,
BALTIMORE--(BUSINESS WIRE)--Medifast, Inc. (NYSE: MED), the metabolic health and wellness company known for its science-backed, coach-guided lifestyle system, today announced the company's Board of Directors has agreed to nominate Parsa Kiai and Jeff Rose from Steamboat Capital Partners LLC as independent director candidates to stand for election at the company's 2026 Annual Meeting of Stockholders, which is…
Medifast (MED) reported earnings 30 days ago. What's next for the stock?
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for MED.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.